Skip to main content

Granisetron Hydrochloride Injection Shortage

Last Updated: April 23, 2024
Status: Current

Products Affected - Description
    • Granisetron Hydrochloride intravenous injection, Fresenius Kabi, 1 mg/mL, 1 mL single dose vial, 1 count, NDC 63323-0318-01
    • Granisetron Hydrochloride intravenous injection, Hikma, 1 mg/mL, 1 mL single dose vial, 10 count, NDC 00143-9744-10
    • Granisetron Hydrochloride intravenous injection, Hikma, 1 mg/mL, 4 mL multiple dose vial, 10 count, NDC 00143-9745-05
Reason for the Shortage
    • Fresenius Kabi did not provide a reason for the shortage.
    • Hikma did not provide a reason for the shortage.
    • Viatris has granisetron injection available.
Available Products
    • Granisetron Hydrochloride intravenous injection, Mylan (Viatris), 1 mg/mL, 1 mL single dose vial, 1 count, NDC 67457-0863-01
    • Granisetron Hydrochloride intravenous injection, Mylan (Viatris), 1 mg/mL, 4 mL multiple dose vial, 1 count, NDC 67457-0864-04

Estimated Resupply Dates

    • Fresenius Kabi has granisetron 1 mg/mL 1 mL vials on back order and the company estimates a release date of mid-June 2024.
    • Hikma has granisetron 1 mg/mL 1 mL and 4 mL vials on back order and the company estimates a release date of late-May 2024.

Updated

Created April 23, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.